Insider trade

Insulet Corporation (PODD)Officer sold ~$239K

Prem Singh, Officer at Insulet Corporation, sold ~$239K of Insulet Corporation shares.

~$239K
Approx. value · 687 sh @ $347.49
3,456
Holds after · shares reported
Traded
Sep 8, 2025
Filed
Sep 9, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 3, 2023CongressDisclosed purchase of PODD — reported range $1,001 - $15,000
  2. Jan 4, 2024CongressDisclosed sale of PODD — reported range $1,001 - $15,000
  3. Aug 7, 2025InsiderOfficer sold ~$430K of PODD shares in the open market
  4. Aug 21, 2025InsiderOfficer sold ~$1.42M of PODD shares in the open market
  5. Sep 8, 2025 · this disclosureInsiderOfficer sold ~$239K of PODD shares in the open market

What came next

  1. Sep 8, 2025InsiderOfficer sold ~$278K of PODD shares in the open market
  2. Sep 11, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On September 16, 2025, Insulet Corporation (the “Company”) announced that Flavia H. Pease has been appointed to succeed Ana M. Chadwick as Executive Vice President and Chief Financial Officer of the Company.”
  3. Sep 11, 2025FDARecall: The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying…
  4. Oct 21, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“O n October 21, 2025, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Robbie Huffines as a Class II director, effective October 31, 2025.”
  5. Oct 30, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 12.5%
  6. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  7. Dec 3, 2025FDAFDA device clearance: Omnipod 5 algorithm
  8. Dec 5, 2025Insider · 6 days before an 8-KDirector purchased ~$300K of PODD shares in the open market
  9. Dec 11, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 11, 2025, the Committee approved the amendment and restatement of the Company’s Annual Incentive Plan (the “Plan”), effective January 1, 2026, except as otherwise specified therein.”
  10. Dec 15, 2025Company filing · Form 8-K · Auditor changeChanged its auditor“On December 15, 2025, following careful deliberation and a competitive process, the Audit Committee (the “Committee”) of the Board of Directors of Insulet Corporation (the “Company”) approved the appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm, subject to completion of standard client acceptance procedures, and dismissed Grant Thornton LLP (“Grant…”
  11. Dec 15, 2025InsiderDirector sold ~$543K of PODD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Insulet Corporation

For Insulet Corporation, OQRO holds 1 Congress trade report and 12 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PODD page.

Other recent filings by Prem Singh, SVP, Global Operations

The full history of Prem Singh, SVP, Global Operations is on the profile page.

How this filing works

Other disclosures at Insulet Corporation

Everything OQRO holds on this company is on its PODD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data